Systemic Lupus Erythematosus

Rheumatologists on the Move

Jessica Kinsella | May 1, 2014

Awards, appointments and announcements in the world of rheumatology

7 Things Ophthalmologists Want Rheumatologists to Know

Vanessa Caceres | May 1, 2014

Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | April 2, 2014

Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know

MicroRNA-Based Therapeutics Hold Promise Against Lupus, Other Rheumatic Diseases Note Experts at the ACR/ARHP’s 2013 Annual Meeting

Susan Bernstein | April 2, 2014

Studies suggest deregulation, dysfunction of miRNAs in human, mice models of lupus may be future targets for gene therapy

Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments

Staff | April 2, 2014

Foundation joins Accelerating Medicines Partnership, led by National Institutes of Health, to fast-track viable potential drug therapies for lupus, rheumatoid arthritis

ACR Board of Directors Tackles Slate of Business at Annual Meeting

Staff | April 2, 2014

Board welcomes 233 new and returning candidates, lends support to lupus classification criteria in partnership with EULAR, approves update of ACR policy statements and position statements at February meeting in Napa, Calif.

Switches That Regulate Gene Expression Offer Better Understanding of Rheumatic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting

Mary Beth Nierengarten | March 1, 2014

New studies examine why turning on or off switches in genes that control the genome can contribute to pathogenesis of such autoimmune diseases as systemic lupus erythematosus or rheumatoid arthritis